Exco InTouch announces the appointment of Mark Brincat as Product Development Director. Brincat brings to Exco InTouch a wealth of experience in progressing innovative and visionary concepts into proven regulatory compliant products that offer tangible benefits to biopharmaceutical sponsors. The new appointment will see Brincat lead the strategy and development of Exco InTouch’s range of patient-centric services and mHealth solutions, with particular focus on the advancement of engagement solutions targeted to specific therapy areas that can be pre-configured to the challenges of a particular disease and patient population.

Brincat joins Exco InTouch from Pfizer, where he spent the last thirteen years managing the delivery of emerging and innovative business technology. Recognized as one of the Pfizers leading innovators, Brincat most recently led its Healthcare Informatics in Europe, during which time he developed pioneering solutions across clinical trials, drug compliance, disease management and wellness. Also, during his time at Pfizer, Brincat managed the first ever remote patient clinical trial, which was supported by Exco’s mobile diary technology. Brincat has previously worked as a softwareengineer for a number of blue chip organizations across multiple industries, throughout which the delivery of innovative technology solutions has been a key theme.

Brincat comments: “I am very excited to be joining the Exco InTouch team. This company has built a solid reputation as an effective and innovativeprovider of patient engagement solutions in one of the most stringent regulatory environments. I believe that Exco InTouch has developed technology foundations and capabilities from which it will build the next generation of leading mHealth solutions". Brincat continues: "We all know that healthcare is at a crossroads, so there is no better time to be working with pharmaceutical and healthcare providers to deliver effective and innovative new mHealth solutions directly to patients".

Tim Davis, CEO, Exco InTouch comments: “At Exco InTouch we believe in continued innovation and strive to develop a service that makes healthcare more efficient, effective, accessible and patient-centric. The addition of Mark’s capabilities to the team further enhances our ability to achieve these objectives. As Product Development Director, Mark will play a hands-on role in defining the requirements for building a product set across our range of trial and mHealth solutions that are targeted to different diseases and their specific challenges. We look forward to developing customized solutions that will reduce medical costs, remove geographical disparities, enhance patients' access to medicines and, fundamentally, improve accuracy of patient information.”